Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Cost blocks public access to RSV protection for babies

High costs are preventing newly approved maternal vaccines and antibody treatments for RSV from entering South Africa's public healthcare system, leaving vulnerable infants without protection.

Cost blocks public access to RSV protection for babies

We haven't written up this one. Mail and Guardian has the full story — the link below goes straight to it.

Read the original at mg.co.za →

More in Health & Medicine

More from Tuesday 22 September →